Latest Incyte News & Updates

See the latest news and media coverage for Incyte. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Incyte

Global biopharmaceutical company

incyte.com
Headquarters
Wilmington, United States
Company type
Public company
Number of employees
3,000–5,000

Last updated

Latest news about Incyte

In short: Incyte reported a 21% first-quarter revenue increase for 2026 and achieved several regulatory approvals, including FDA clearance for Jakafi XR.

Company announcements

  • Incyte

    Incyte announces 24-week data from TRuE-AD4 trial

    84.3% of patients achieved EASI75 and 70.6% IGA-TS with Opzelura cream in moderate atopic dermatitis. Data presented at EADV Symposium. Supports EU approval application.

  • Incyte

    Incyte appoints Suketu Upadhyay as CFO

    He brings extensive healthcare experience and a strong track record in leading finance organizations.

  • Incyte

    Incyte announces FDA approval of Jakafi XR

    The once-daily extended-release tablets treat myelofibrosis, polycythemia vera, and graft-versus-host disease. Availability starts May 8.

  • Incyte

    Incyte appoints Suketu Upadhyay as CFO

    Effective May 4, 2026, he will lead global finance, strategic planning, and investor relations. Upadhyay brings extensive experience from Zimmer Biomet and Bristol Myers Squibb.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Incyte

Track Incyte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Incyte competitors & trending companies

Browse news for competitors to Incyte and other trending companies.